Gastroenterologia e Endoscopia Digestiva

css home

Telefono: 0882 410785
Fax: 0882 835411
E-Mail:

f.perri@operapadrepio.it

Dirigente Medico Responsabile: Dott. Francesco Perri

Iacobellis Angelo

Informazioni aggiuntive

  • Cognome Nome: Iacobellis Angelo
  • Dipartimento: Scienze Mediche
  • Reparto: Gastroenterologia e Endoscopia Digestiva
  • Qualifica: Dirigente Medico
  • Telefono Reparto: 0882410785
  • Pubblicazioni Scientifiche: Elenco Pubblicazioni Scientifiche

    Totale pubblicazioni a partire dal 2011: 18


    2019; 70(4): 1336-1348

    Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).

    Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A, Makara M, Ben Ari Z, Braun M, Mitrut P, Yang SS, Akdogan M, Pirisi M, Duggal A, Ochiai T, Motomiya T, Kano T, Nagata T, Afdhal N


    2018; 6(2): 225-237

    Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

    Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A, ITAL-C consortium.


    2017; ():

    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

    Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F


    2017; ():

    Hepatitis C Virus Clearance in Older Adults.

    Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A


    2017; 45(9): 1193-1200

    Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.

    Guarino M, Morisco F, Valvano MR, Ippolito AM, Librandi M, Andriulli N, Greco M, Amoruso A, Iacobellis A, Niro G, Caporaso N, Andriulli A


    2016; ():

    Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

    Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, Siena D, Caruso M, Ippolito A, Mannuccio PM, Andriulli A


    2016; ():

    Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis Pain.

    Iacobellis A, Seripa D, Palmieri O, Andriulli N, Latina P


    World journal of hepatology 2016; 8(22): 949-56

    Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

    Cleo Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D'Adamo G, D'Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Gia


    Alimentary pharmacology and therapeutics 2016; ():

    HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

    Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M


    2016; ():

    Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.

    Violi F, Corazza RG, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S, PRO-LIVER Collaborators


    2014; ():

    Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

    Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


    AISD - 36° Congresso Nazionale 2013; : 55

    Safety and efficacy of effentora to treat acute moderate oncological pain in a cirrhotic patient without previous strong opioid therapy

    Latina P., Andriulli A., Niro A., Conoscitore P., Ippolito A., Nardella M., Iacobellis A.

    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2012; ():

    Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


    2012; 56: s426

    PEG-interferon and ribavirin in HCV-related cirrhotic patients with profound thrombocytopenia

    Andriulli A, Iacobellis A, Iannacone C, Angarano G, Adinolfi A, Persico M, Mangia A, Fattovich G, Capra F, Rizzetto M, Golotta C

    2012; 56: s427

    A substantial proportion of naive HCV-1 infected patients with chronic infection may benefit from current standard therapy with PEG-interferon and ribavirin

    Andriulli A, Valvano MR, Spirito F, Ippolito A, Iacobellis A, Bossa F, Terracciano F, Niro G

    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


nuovo-css

  twitter   facebook   youtube